Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
January 31, 2024
 · 
Reactions
MyLungCancerTeam

Gemcitabine is one of the chemotherapy drugs used for treating advanced non-small cell lung cancer (NSCLC). It is often used when other treatments are no longer effective. Here are some key points about Gemcitabine:

- Administration: Given through an intravenous (IV) infusion
- Mechanism: Travels through the bloodstream Show Full Answer

Gemcitabine is one of the chemotherapy drugs used for treating advanced non-small cell lung cancer (NSCLC). It is often used when other treatments are no longer effective. Here are some key points about Gemcitabine:

- Administration: Given through an intravenous (IV) infusion.
- Mechanism: Travels through the bloodstream to target and kill cancer cells.
- Side Effects: Can affect normal, rapidly dividing cells such as hair follicles, blood cells in the bone marrow, and cells in the digestive tract and mouth.

If you have specific concerns or experiences, discussing them with your healthcare team can provide personalized guidance.

July 29, 2024
A MyLungCancerTeam Member

I'm sorry it stopped working. Hope they get you a good replacement treatment!

July 29, 2024
A MyLungCancerTeam Member

Spell check Abraxe

January 31, 2024

Related Questions

View All
A MyLungCancerTeam Member asked a question 💭
Glace Bay, NS

A MyLungCancerTeam Member asked a question 💭
Cincinnati, OH

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In